Kazeem Babatunde Yusuff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kazeem Babatunde Yusuff has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Fola Tayo
University of Lagos
5 shared publicationsHager ElGeed
Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health Sector, Qatar University, Doha, Qatar
3 shared publications- Ibrahim Abayomi Ogunyinka
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria
3 shared publications Mohamed Izham Mohamed Ibrahim
Affiliation Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, Qatar
3 shared publicationsAhmed Awaisu
Qatar Univ, Coll Pharm, Dept Clin Pharm & Practice, QU Hlth, Doha, Qatar
2 shared publications- Ahmed Awaisu
Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar
2 shared publications
Latest Publications
- 24 April 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- p. 1-14
Analgesic Utilization Pattern and Cost of Managing Children with Sickle Cell Diseases: a Retrospective Single-site Audit
Background Information Sickle cell disease (SCD), a β-haemoglobinopathy, is a neglected multi-system disorder caused by inherited abnormal haemoglobin structure or production and leads to catastrophic economic burden on affected households and societies. We assessed the predictors of both SCD severity and SCD care costs. Methods This is a retrospective chart review of eligible children with SCD in a developing setting. Their sociodemographic, clinical and costs data were collected and analyzed using SPSS version 26.0 with p ≤ 0.05 considered significant. Results Overall 2503 children with SCD (female: 1053 [51.3%]; median (interquartile range) age: 4.00 (5.75) years and range age: 0.08–14.00 years) participated in the study with their median (interquartile range) age at first pain crisis, age at first hospitalization, costs of outpatient, inpatient and total patient care; analgesics and laboratory investigations being 1.00 (1.25) years, 1.00 (1.13) years, 89.8 (110.6) USD, 47.9 (63.4) USD and 200.4 (158.8) USD; 3.8 (3.5) USD and 28.6 (16.9) USD respectively. The major predictors of SCD severity were [hospitalization frequency: use of parenteral non-opioids (odds ratio (OR): 8.65; 95% CI:3.84–19.46; p < 0.001) and having a history of parental consanguinity (OR: 6.28; 95% CI:1.59–24.86; p = 0.009); hospitalization duration: having a history of parental consanguinity (OR: 3.73; 95% CI:2.03–6.83; p < 0.001) and type of oral analgesics (OR: 3.28; 95% CI:2.57–4.17; p < 0.001)]. The major predictors of the following cost variables were: analgesics [total amount of non-opioids (OR: 2.34; 95% CI:2.10–2.60; p < 0.001) and total number of oral opioids (OR: 4.56; 95% CI:3.60–5.78; p < 0.001)]; laboratory investigation [total amount of oral opioids (OR: 1.41; 95% CI:1.27–1.56; p = 0.0005)]; outpatient care [school attendance (OR: 20.64; 95% CI:10.47–40.69; p < 0.001), comorbidity (OR: 2.68; 95% CI:1.52–4.75; p < 0.001) and pentazocine (OR: 1.32; 95% CI:1.12–1.56; p < 0.001)]; inpatient care [having a history of parental consanguinity (OR: 10.67; 95% CI:4.81–23.67; p < 0.001)] and total patient care [pentazocine (OR: 14.75; 95% CI:10.17–35.68; p < 0.001)]. Conclusion Consanguinity and analgesics use were the major predictors of both SCD severity and SCD care costs.
- 24 April 2026
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- p. 1-14
Analgesic Utilization Pattern and Cost of Managing Children with Sickle Cell Diseases: a Retrospective Single-site Audit
Background Information Sickle cell disease (SCD), a β-haemoglobinopathy, is a neglected multi-system disorder caused by inherited abnormal haemoglobin structure or production and leads to catastrophic economic burden on affected households and societies. We assessed the predictors of both SCD severity and SCD care costs. Methods This is a retrospective chart review of eligible children with SCD in a developing setting. Their sociodemographic, clinical and costs data were collected and analyzed using SPSS version 26.0 with p ≤ 0.05 considered significant. Results Overall 2503 children with SCD (female: 1053 [51.3%]; median (interquartile range) age: 4.00 (5.75) years and range age: 0.08–14.00 years) participated in the study with their median (interquartile range) age at first pain crisis, age at first hospitalization, costs of outpatient, inpatient and total patient care; analgesics and laboratory investigations being 1.00 (1.25) years, 1.00 (1.13) years, 89.8 (110.6) USD, 47.9 (63.4) USD and 200.4 (158.8) USD; 3.8 (3.5) USD and 28.6 (16.9) USD respectively. The major predictors of SCD severity were [hospitalization frequency: use of parenteral non-opioids (odds ratio (OR): 8.65; 95% CI:3.84–19.46; p < 0.001) and having a history of parental consanguinity (OR: 6.28; 95% CI:1.59–24.86; p = 0.009); hospitalization duration: having a history of parental consanguinity (OR: 3.73; 95% CI:2.03–6.83; p < 0.001) and type of oral analgesics (OR: 3.28; 95% CI:2.57–4.17; p < 0.001)]. The major predictors of the following cost variables were: analgesics [total amount of non-opioids (OR: 2.34; 95% CI:2.10–2.60; p < 0.001) and total number of oral opioids (OR: 4.56; 95% CI:3.60–5.78; p < 0.001)]; laboratory investigation [total amount of oral opioids (OR: 1.41; 95% CI:1.27–1.56; p = 0.0005)]; outpatient care [school attendance (OR: 20.64; 95% CI:10.47–40.69; p < 0.001), comorbidity (OR: 2.68; 95% CI:1.52–4.75; p < 0.001) and pentazocine (OR: 1.32; 95% CI:1.12–1.56; p < 0.001)]; inpatient care [having a history of parental consanguinity (OR: 10.67; 95% CI:4.81–23.67; p < 0.001)] and total patient care [pentazocine (OR: 14.75; 95% CI:10.17–35.68; p < 0.001)]. Conclusion Consanguinity and analgesics use were the major predictors of both SCD severity and SCD care costs.
- Open Access
- 13 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342795
Predictors of community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar
There is a paucity of studies focused on the predictors of community pharmacists’ readiness to deprescribe inappropriate medications for older adults especially in developing settings. The study aimed to use the situational theory of leadership to determine community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults, and as well as its significant predictors. A theory-driven cross-sectional assessment of the readiness (knowledge and confidence) of 252 community pharmacists was conducted in Qatar with a pre-tested 40-item questionnaire. Knowledge and confidence were assessed with a 2-point and 4-point Likert-type scale respectively. The maximum obtainable score for readiness was 16. Readiness was categorized as high (≥ median) or low (<median). Bivariate logistic regression was used to identify the significant predictors. The response rate was 79.4% (200). The majority of the community pharmacists were females (54.5%), within the age range of 20–40 years (88.0%), had BSc / BPharm as the highest educational qualification (70.5%), were full-time employee (97.0%) and consisted mainly of 5 nationalities (91.0%). The median (IQR) readiness score for community pharmacists was 13 (4) (minimum = 4, maximum = 16). Overall, 54.4% (109) of community pharmacists reported high confidence score (≥ median), while 60.5% (121) reported high knowledge score (≥ median). Readiness score was significantly higher among female community pharmacists (p = 0.048) and respondents who reported exposure to deprescribing in undergraduate training (p = 0.001). Overall, community pharmacists felt knowledgeable and confident to implement deprescribing of inappropriate medicines for older adults. However, a number of critical readiness gaps requiring educational interventions especially regarding how to access and use deprescribing toolkits and algorithms were identified. The most significant predictors of community pharmacists’ readiness were gender (female) and exposure to deprescribing in undergraduate training.
- 13 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342795
Open AccessPredictors of community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar
There is a paucity of studies focused on the predictors of community pharmacists’ readiness to deprescribe inappropriate medications for older adults especially in developing settings. The study aimed to use the situational theory of leadership to determine community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults, and as well as its significant predictors. A theory-driven cross-sectional assessment of the readiness (knowledge and confidence) of 252 community pharmacists was conducted in Qatar with a pre-tested 40-item questionnaire. Knowledge and confidence were assessed with a 2-point and 4-point Likert-type scale respectively. The maximum obtainable score for readiness was 16. Readiness was categorized as high (≥ median) or low (<median). Bivariate logistic regression was used to identify the significant predictors. The response rate was 79.4% (200). The majority of the community pharmacists were females (54.5%), within the age range of 20–40 years (88.0%), had BSc / BPharm as the highest educational qualification (70.5%), were full-time employee (97.0%) and consisted mainly of 5 nationalities (91.0%). The median (IQR) readiness score for community pharmacists was 13 (4) (minimum = 4, maximum = 16). Overall, 54.4% (109) of community pharmacists reported high confidence score (≥ median), while 60.5% (121) reported high knowledge score (≥ median). Readiness score was significantly higher among female community pharmacists (p = 0.048) and respondents who reported exposure to deprescribing in undergraduate training (p = 0.001). Overall, community pharmacists felt knowledgeable and confident to implement deprescribing of inappropriate medicines for older adults. However, a number of critical readiness gaps requiring educational interventions especially regarding how to access and use deprescribing toolkits and algorithms were identified. The most significant predictors of community pharmacists’ readiness were gender (female) and exposure to deprescribing in undergraduate training.
- Open Access
- 30 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0316363
Enablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar
There is paucity of studies focused on the enablers and barriers to community pharmacists’ readiness to deprescribe inappropriate medications for older adults in developing settings. The current study assessed the enablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults. A cross-sectional survey of 252 community pharmacists was conducted in Qatar with a pre-tested 24-item questionnaire developed with the theory of domain framework. Information about perceived enablers and barriers were elicited with a 5-point Likert-type scale. The response rate was 79.4% (200/252). The majority of the community pharmacists were females (54.5%), within the age range of 20–40 years (88.0%), had BSc / BPharm as the highest educational qualification (70.5%), were full-time employee (97.0%). The top-ranked enablers of community pharmacists’ readiness to implement deprescribing were exposure to CPD on the use of deprescribing toolkits and algorithm (66%), interprofessional collaboration with physicians (60.5%) and shared electronic patient record (59.5%), and improved remuneration / re-imbursement 58%). The top-ranked barriers were lack of access to patient records (70.5%), ineffective collaboration with physicians (66.5%), lack of time due to heavy workload (65%), regulatory framework that limit expansion of clinical roles (51%) and intense focus on sales target (49%). The top-ranked enablers of community pharmacists’ readiness to implement deprescribing were exposure to CPD on the use of deprescribing toolkits and algorithm, interprofessional collaboration with physicians and shared electronic patient record. These findings bode well for the implementation of community pharmacists-led deprescribing of inappropriate medications for older adults in Qatar. However, a number of critical barriers were identified, and these will require institutional, regulatory and organizational interventions to improve readiness.
- 30 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0316363
Open AccessEnablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar
There is paucity of studies focused on the enablers and barriers to community pharmacists’ readiness to deprescribe inappropriate medications for older adults in developing settings. The current study assessed the enablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults. A cross-sectional survey of 252 community pharmacists was conducted in Qatar with a pre-tested 24-item questionnaire developed with the theory of domain framework. Information about perceived enablers and barriers were elicited with a 5-point Likert-type scale. The response rate was 79.4% (200/252). The majority of the community pharmacists were females (54.5%), within the age range of 20–40 years (88.0%), had BSc / BPharm as the highest educational qualification (70.5%), were full-time employee (97.0%). The top-ranked enablers of community pharmacists’ readiness to implement deprescribing were exposure to CPD on the use of deprescribing toolkits and algorithm (66%), interprofessional collaboration with physicians (60.5%) and shared electronic patient record (59.5%), and improved remuneration / re-imbursement 58%). The top-ranked barriers were lack of access to patient records (70.5%), ineffective collaboration with physicians (66.5%), lack of time due to heavy workload (65%), regulatory framework that limit expansion of clinical roles (51%) and intense focus on sales target (49%). The top-ranked enablers of community pharmacists’ readiness to implement deprescribing were exposure to CPD on the use of deprescribing toolkits and algorithm, interprofessional collaboration with physicians and shared electronic patient record. These findings bode well for the implementation of community pharmacists-led deprescribing of inappropriate medications for older adults in Qatar. However, a number of critical barriers were identified, and these will require institutional, regulatory and organizational interventions to improve readiness.
- 22 March 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (4) , 100690
Pharmacy Students’ Perception of the Content and Delivery of Drug Information Training: A Mixed-Methods Study
- 22 March 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (4) , 100690
Pharmacy Students’ Perception of the Content and Delivery of Drug Information Training: A Mixed-Methods Study
- 25 November 2022
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 29 (7) , 1580-1589
Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting
Background: There is a paucity of studies about the readiness of community pharmacists to manage the safe and effective use of oral anticancer medicines (OAMs) in developing settings. Objectives: Using the readiness component (knowledge and willingness) of the situational theory of leadership, the study assessed community pharmacists’ readiness to manage the safe and effective use of OAMs in Qatar, and also identified its significant predictors. Methods: A cross-sectional assessment of 252 community pharmacists was conducted with a pre-tested 48-item questionnaire. Readiness was assessed with a 5-point Likert-type scale and the maximum obtainable score was 70. The mean was used as the cut-off point to categorize willingness and knowledge as either high (≥ mean) or low (< mean). Independent t-test, one-way analysis of variance and multiple linear regression was used for data analyses. Results: The mean SD score for the readiness of community pharmacists was 39.3 ± 11.2 (min = 11, max = 70). Only a minority of the respondents expressed an excellent understanding of the chemotherapy cycles (19.6%; 45/230), and familiarity with targeted anticancer therapy (14.3%; 33/230), side effects (22.2%; 51/230), and dosing of OAMs (14.4%; 33/230). Employment status, number of OAMs prescriptions dispensed per month and adequacy of the contents related to OAMs in undergraduate training were the significant predictors of readiness ( R2 = 0.558, (F (11, 209) = 3.559, p = 0.0001). Conclusions: Community pharmacists’ readiness appear inadequate especially regarding its dosing, side effects, handling, and disposal of OAMs. These inadequacies probably underline community pharmacists’ low familiarity and comfortability with dispensing and educating patients on the effective and safe use of OAMs.
- 25 November 2022
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 29 (7) , 1580-1589
Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting
Background: There is a paucity of studies about the readiness of community pharmacists to manage the safe and effective use of oral anticancer medicines (OAMs) in developing settings. Objectives: Using the readiness component (knowledge and willingness) of the situational theory of leadership, the study assessed community pharmacists’ readiness to manage the safe and effective use of OAMs in Qatar, and also identified its significant predictors. Methods: A cross-sectional assessment of 252 community pharmacists was conducted with a pre-tested 48-item questionnaire. Readiness was assessed with a 5-point Likert-type scale and the maximum obtainable score was 70. The mean was used as the cut-off point to categorize willingness and knowledge as either high (≥ mean) or low (< mean). Independent t-test, one-way analysis of variance and multiple linear regression was used for data analyses. Results: The mean SD score for the readiness of community pharmacists was 39.3 ± 11.2 (min = 11, max = 70). Only a minority of the respondents expressed an excellent understanding of the chemotherapy cycles (19.6%; 45/230), and familiarity with targeted anticancer therapy (14.3%; 33/230), side effects (22.2%; 51/230), and dosing of OAMs (14.4%; 33/230). Employment status, number of OAMs prescriptions dispensed per month and adequacy of the contents related to OAMs in undergraduate training were the significant predictors of readiness ( R2 = 0.558, (F (11, 209) = 3.559, p = 0.0001). Conclusions: Community pharmacists’ readiness appear inadequate especially regarding its dosing, side effects, handling, and disposal of OAMs. These inadequacies probably underline community pharmacists’ low familiarity and comfortability with dispensing and educating patients on the effective and safe use of OAMs.
- 18 August 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (1) , 58-65
Predictors of enablers and barriers to community pharmacists’ management of minor ailments in a developing setting: A theory-driven assessment
- 18 August 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (1) , 58-65
Predictors of enablers and barriers to community pharmacists’ management of minor ailments in a developing setting: A theory-driven assessment
- Open Access
- 14 March 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (3) , e0010259
Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment
Background: The year 2020 Lassa fever (LF) outbreak had the greatest disease burden and this can place an enormous strain on the already overstretched healthcare system and can potentially increase morbidity and mortality due to infectious diseases. Therefore, having a knowledgeable healthcare workforce with appropriate skills and competencies to prevent and manage outbreaks of a neglected infectious disease such as LF in Nigeria will potentially enhance public health. Thus, this survey assessed the level of knowledge of LF and its prevention and control (PC) measures amongst the healthcare workers (HCWs) during a LF outbreak in Katsina state, Nigeria. Methodology/Principal findings: During this cross-sectional survey, HCWs complete a validated 29-item questionnaire comprising 18 items on the knowledge of LF and its PC measures and an item on global self-evaluation of their LF knowledge. Psychometric properties of the questionnaire were evaluated. Chi-square and binary logistic regression analyses were conducted. Out of 435 HCWs invited, a total of 400 participated in the study (92% response rate). The majority of participants (51.8%) demonstrated inadequate LF knowledge, with 62.9% of those scoring low having a high self-perception of their LF knowledge with the global scale. This LF knowledge over-estimation was predicted by LF training status (odds ratio (OR) 2.53; 95% CI: 1.49–4.30; p = 0.001). The level of LF knowledge and its PC measures among the study participants was low (11.60±8.14, 64.4%) and predicted by participants’ LF training status (OR 2.06; 95% CI: 1.19–3.57; p = 0.009), place of work (OR 1.82; 95% CI: 1.07–3.08; p = 0.03) and their designations (OR 2.40; 95% CI: 1.10–5.22; p = 0.03). Conclusion: The level of knowledge of LF and its PC measures among the HCWs surveyed was suboptimal and participants’ LF training status, place of work and occupational category were the significant predictors. In addition, LF knowledge overestimation on a global scale was observed among a majority of HCWs and this was also predicted by LF training status. Therefore, there is a critical need for health authorities in Nigeria to prioritize continuous on-the-job training of HCWs on priority neglected tropical diseases such as Lassa fever.
- 14 March 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (3) , e0010259
Open AccessKnowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment
Background: The year 2020 Lassa fever (LF) outbreak had the greatest disease burden and this can place an enormous strain on the already overstretched healthcare system and can potentially increase morbidity and mortality due to infectious diseases. Therefore, having a knowledgeable healthcare workforce with appropriate skills and competencies to prevent and manage outbreaks of a neglected infectious disease such as LF in Nigeria will potentially enhance public health. Thus, this survey assessed the level of knowledge of LF and its prevention and control (PC) measures amongst the healthcare workers (HCWs) during a LF outbreak in Katsina state, Nigeria. Methodology/Principal findings: During this cross-sectional survey, HCWs complete a validated 29-item questionnaire comprising 18 items on the knowledge of LF and its PC measures and an item on global self-evaluation of their LF knowledge. Psychometric properties of the questionnaire were evaluated. Chi-square and binary logistic regression analyses were conducted. Out of 435 HCWs invited, a total of 400 participated in the study (92% response rate). The majority of participants (51.8%) demonstrated inadequate LF knowledge, with 62.9% of those scoring low having a high self-perception of their LF knowledge with the global scale. This LF knowledge over-estimation was predicted by LF training status (odds ratio (OR) 2.53; 95% CI: 1.49–4.30; p = 0.001). The level of LF knowledge and its PC measures among the study participants was low (11.60±8.14, 64.4%) and predicted by participants’ LF training status (OR 2.06; 95% CI: 1.19–3.57; p = 0.009), place of work (OR 1.82; 95% CI: 1.07–3.08; p = 0.03) and their designations (OR 2.40; 95% CI: 1.10–5.22; p = 0.03). Conclusion: The level of knowledge of LF and its PC measures among the HCWs surveyed was suboptimal and participants’ LF training status, place of work and occupational category were the significant predictors. In addition, LF knowledge overestimation on a global scale was observed among a majority of HCWs and this was also predicted by LF training status. Therefore, there is a critical need for health authorities in Nigeria to prioritize continuous on-the-job training of HCWs on priority neglected tropical diseases such as Lassa fever.
- Open Access
- 3 December 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (12) , e0260992
Prevalence, types and severity of medication errors associated with the use of automated medication use systems in ambulatory and institutionalized care settings: A systematic review protocol
The use of automated systems within the medication use process has significantly reduce the occurrence of medication errors and the associated clinical and financial burden. However, automated systems lull into a false sense of security and increase the risk of medication errors that are often associated with socio-technical interactions, automation bias, workarounds and overrides. The objective of the systematic review is to determine the prevalence, types and severity of medication errors that are associated the use of automated systems in ambulatory and institutionalized care settings. The search strategy will be guided by PRISMA framework. Selected databases and relevant gray literature were searched and screening was done independently by two researchers between 01 April and 29 June 2021. These covered all relevant articles published from the inception of the use of automation in the medication use process (2000) until 2020. De-duplication and screening of all studies were done independently by two researchers with a clear inclusion / exclusion criteria. Data extraction and synthesis are currently on going (started on 06 July 2021) and being conducted independently but the validity and completeness of the processes will be confirmed by the third researcher. The Cochrane Risk of Bias tool and the Hoy et al’s quality assessment checklist will be used for the assessment of methodological bias while the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used for the quality of evidence assessment. Detailed qualitative synthesis of key findings will be done with thematic and descriptive analyses. If the number and types of included studies permit, fixed or random effect model meta-analysis will be conducted based on the degree of homogeneity in the sampling frame used in the included studies. Heterogeneity will be assessed with I2 statistics and I2 > 50% will be considered a high statistical heterogeneity. The systematic review may provide new perspective especially from developing settings about the prevalence, types and severity of medication errors associated with the use of automated systems at all the stages of medication use process, and in all categories of patients. This may add to global knowledge in the research area. Systematic review registration: The systematic review was registered and published by PROSPERO (CRD42020212900).
- 3 December 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (12) , e0260992
Open AccessPrevalence, types and severity of medication errors associated with the use of automated medication use systems in ambulatory and institutionalized care settings: A systematic review protocol
The use of automated systems within the medication use process has significantly reduce the occurrence of medication errors and the associated clinical and financial burden. However, automated systems lull into a false sense of security and increase the risk of medication errors that are often associated with socio-technical interactions, automation bias, workarounds and overrides. The objective of the systematic review is to determine the prevalence, types and severity of medication errors that are associated the use of automated systems in ambulatory and institutionalized care settings. The search strategy will be guided by PRISMA framework. Selected databases and relevant gray literature were searched and screening was done independently by two researchers between 01 April and 29 June 2021. These covered all relevant articles published from the inception of the use of automation in the medication use process (2000) until 2020. De-duplication and screening of all studies were done independently by two researchers with a clear inclusion / exclusion criteria. Data extraction and synthesis are currently on going (started on 06 July 2021) and being conducted independently but the validity and completeness of the processes will be confirmed by the third researcher. The Cochrane Risk of Bias tool and the Hoy et al’s quality assessment checklist will be used for the assessment of methodological bias while the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used for the quality of evidence assessment. Detailed qualitative synthesis of key findings will be done with thematic and descriptive analyses. If the number and types of included studies permit, fixed or random effect model meta-analysis will be conducted based on the degree of homogeneity in the sampling frame used in the included studies. Heterogeneity will be assessed with I2 statistics and I2 > 50% will be considered a high statistical heterogeneity. The systematic review may provide new perspective especially from developing settings about the prevalence, types and severity of medication errors associated with the use of automated systems at all the stages of medication use process, and in all categories of patients. This may add to global knowledge in the research area. Systematic review registration: The systematic review was registered and published by PROSPERO (CRD42020212900).
- Open Access
- 1 November 2021
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 14, 4595-4607
Community Pharmacists’ Knowledge and Attitudes Towards Pediatric Pain Management in Nigeria
Purpose: Community pharmacists (CPs) frequently attend to pediatric patients with pain but limited data exist regarding their knowledge of and attitude to effective management of pediatric pain in Nigeria. Thus, this study aimed to evaluate the knowledge of and attitude to pediatric pain management among CPs in Nigeria. Patients and Methods: A validated and pilot-tested questionnaire, the Community Pharmacists Survey on Pediatric Pain, was administered to 517 eligible participants at the 38th Annual National Conference of the Association of Community Pharmacists of Nigeria. Independent samples t-test and one-way analysis of variance were used for inferential statistical analyses. Results: CPs with additional higher academic qualifications and clinically related additional academic degrees had significantly higher mean knowledge scores relative to first degree only holder counterpart (t= 4.33, p< 0.05, Eta2=0.05) and those without clinically related second degrees (t= 6.34, p< 0.05, Eta2=0.27). Pain knowledge among the study cohort also varied significantly by age group, years of practicing community pharmacy, ownership structure of premises, geographical location of practice and previous exposure to pain management training (F(4370)=2.858, p=0.025, Eta2=0.03; F(3371)=3.985, p=0.008, Eta2=0.03; F(2372)=3.643, p=0.027, Eta2=0.02; F(5369)=4.497, p=0.01, Eta2=0.06; F(2372)=3.587, p=0.029, Eta2=0.02), respectively. Conclusion: Community pharmacists’ knowledge of and attitude to pediatric pain management in Nigeria appeared sub-optimal, and requires regular targeted educational intervention to fill the identified gaps, improve service delivery and patient outcomes.
- 1 November 2021
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 14, 4595-4607
Open AccessCommunity Pharmacists’ Knowledge and Attitudes Towards Pediatric Pain Management in Nigeria
Purpose: Community pharmacists (CPs) frequently attend to pediatric patients with pain but limited data exist regarding their knowledge of and attitude to effective management of pediatric pain in Nigeria. Thus, this study aimed to evaluate the knowledge of and attitude to pediatric pain management among CPs in Nigeria. Patients and Methods: A validated and pilot-tested questionnaire, the Community Pharmacists Survey on Pediatric Pain, was administered to 517 eligible participants at the 38th Annual National Conference of the Association of Community Pharmacists of Nigeria. Independent samples t-test and one-way analysis of variance were used for inferential statistical analyses. Results: CPs with additional higher academic qualifications and clinically related additional academic degrees had significantly higher mean knowledge scores relative to first degree only holder counterpart (t= 4.33, p< 0.05, Eta2=0.05) and those without clinically related second degrees (t= 6.34, p< 0.05, Eta2=0.27). Pain knowledge among the study cohort also varied significantly by age group, years of practicing community pharmacy, ownership structure of premises, geographical location of practice and previous exposure to pain management training (F(4370)=2.858, p=0.025, Eta2=0.03; F(3371)=3.985, p=0.008, Eta2=0.03; F(2372)=3.643, p=0.027, Eta2=0.02; F(5369)=4.497, p=0.01, Eta2=0.06; F(2372)=3.587, p=0.029, Eta2=0.02), respectively. Conclusion: Community pharmacists’ knowledge of and attitude to pediatric pain management in Nigeria appeared sub-optimal, and requires regular targeted educational intervention to fill the identified gaps, improve service delivery and patient outcomes.
- Open Access
- 16 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0256156
Management of common minor ailments in Qatar: Community pharmacists’ self-perceived competency and its predictors
Studies focused on comprehensive assessment of self-perceived competency of community pharmacists to manage minor ailments are scanty despite that self-perceived competency is a valid determinant of task performance. The objectives of the study were to assess community pharmacists’ self-perceived competency to manage fourteen common minor ailments in Qatar, and identify its significant predictors. A cross-sectional assessment of 307 community pharmacists was conducted with a pre-tested 20-item questionnaire. Self-perceived competency was assessed with nine elements on a scale of 1–10 (Maximum obtainable score: Each minor ailment = 90; each element = 140). Mann-Whitney U and bivariate logistic regression were used for data analyses. The response rate was 91.9% (282/307). The majority of the respondents were males (68.1%; 192/282), within the age range of 31–40 years (55.3%; 156/282). The minor ailments with the highest median competency score were constipation (76), and cold/catarrh (75) while travel sickness (69), and ringworm (69) had the lowest. The two condition-specific competency elements with the highest median score were recommendation of over-the-counter (OTC) medicines (115), and provision of instructions to guide its use (115). Ability to differentiate minor ailments from other medical conditions had the lowest median competency score (109). The significant predictors self-perceived competency were female gender (OR = 2.39, 95%CI: 1.34–4.25, p = 0.003), and working for chain pharmacies (OR = 2.54, 95%CI: 1.30–4.96, p = 0.006). Overall, Community pharmacists’ self-perceived competency was adequate for majority of the common minor ailments, and it was highest for constipation and cold/catarrh, and specifically for the recommendation of OTC medicines and provision of instructions to guide its use. However, diagnostic ability to differentiate minor ailments from other medical conditions with similar features had the lowest median competency score. Female gender and working in chain pharmacies were the significant predictors of self-perceived competency to manage minor ailments.
- 16 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0256156
Open AccessManagement of common minor ailments in Qatar: Community pharmacists’ self-perceived competency and its predictors
Studies focused on comprehensive assessment of self-perceived competency of community pharmacists to manage minor ailments are scanty despite that self-perceived competency is a valid determinant of task performance. The objectives of the study were to assess community pharmacists’ self-perceived competency to manage fourteen common minor ailments in Qatar, and identify its significant predictors. A cross-sectional assessment of 307 community pharmacists was conducted with a pre-tested 20-item questionnaire. Self-perceived competency was assessed with nine elements on a scale of 1–10 (Maximum obtainable score: Each minor ailment = 90; each element = 140). Mann-Whitney U and bivariate logistic regression were used for data analyses. The response rate was 91.9% (282/307). The majority of the respondents were males (68.1%; 192/282), within the age range of 31–40 years (55.3%; 156/282). The minor ailments with the highest median competency score were constipation (76), and cold/catarrh (75) while travel sickness (69), and ringworm (69) had the lowest. The two condition-specific competency elements with the highest median score were recommendation of over-the-counter (OTC) medicines (115), and provision of instructions to guide its use (115). Ability to differentiate minor ailments from other medical conditions had the lowest median competency score (109). The significant predictors self-perceived competency were female gender (OR = 2.39, 95%CI: 1.34–4.25, p = 0.003), and working for chain pharmacies (OR = 2.54, 95%CI: 1.30–4.96, p = 0.006). Overall, Community pharmacists’ self-perceived competency was adequate for majority of the common minor ailments, and it was highest for constipation and cold/catarrh, and specifically for the recommendation of OTC medicines and provision of instructions to guide its use. However, diagnostic ability to differentiate minor ailments from other medical conditions with similar features had the lowest median competency score. Female gender and working in chain pharmacies were the significant predictors of self-perceived competency to manage minor ailments.